Inogen Inc $ 44.85 -0.61 (-1.34%)
Volume:
264,131
Avg Vol (1m):
333,026
Market Cap $:
986.63 Mil
Enterprise Value $:
793.30 Mil
P/E (TTM):
31.14
P/B:
2.84
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 27.43 | ||
| Equity-to-Asset | 0.77 | ||
| Debt-to-Equity | 0.02 | ||
| Debt-to-EBITDA | 0.17 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 7.9 | ||
| Beneish M-Score | -1.6 | ||
| WACC vs ROIC | |||
Profitability Rank | 8/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 8.09 | ||
| Net Margin % | 8.76 | ||
| ROE % | 10.11 | ||
| ROA % | 8.22 | ||
| ROC (Joel Greenblatt) % | 55.42 | ||
| 3-Year Revenue Growth Rate | 27.5 | ||
| 3-Year EBITDA Growth Rate | 18.3 | ||
| 3-Year EPS without NRI Growth Rate | 60.1 |
Valuation Rank | 10/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 31.14 | ||
| PE Ratio without NRI | 31.14 | ||
| Price-to-Owner-Earnings | 206.69 | ||
| PB Ratio | 2.84 | ||
| PS Ratio | 2.69 | ||
| Price-to-Free-Cash-Flow | 26.96 | ||
| Price-to-Operating-Cash-Flow | 22.99 | ||
| EV-to-EBIT | 24.45 | ||
| EV-to-EBITDA | 17.86 | ||
| EV-to-Revenue | 2.11 | ||
| PEG Ratio | 1.36 | ||
| Current Ratio | 5.79 | ||
| Quick Ratio | 5.11 | ||
| Days Inventory | 56.32 | ||
| Days Sales Outstanding | 40.67 | ||
| Days Payable | 35.85 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 4.28 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 1.43 | ||
| Price-to-Median-PS-Value | 0.44 | ||
| Price-to-Peter-Lynch-Fair-Value | 2.25 | ||
| Price-to-Graham-Number | 2.43 | ||
| Earnings Yield (Greenblatt) % | 4.08 | ||
| Forward Rate of Return (Yacktman) % | 17.1 |